25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MYRIAD GENETICS (MYD.SG)
Buy, Hold or Sell?

Let's analyze MYRIAD GENETICS (MYD.SG) together

I guess you are interested in MYRIAD GENETICS (MYD.SG). Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MYRIAD GENETICS (MYD.SG). At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about MYRIAD GENETICS (MYD.SG)

I send you an email if I find something interesting about MYRIAD GENETICS (MYD.SG).

1. Quick Overview

1.1. Quick analysis of MYRIAD GENETICS (MYD.SG) (30 sec.)










1.2. What can you expect buying and holding a share of MYRIAD GENETICS (MYD.SG)? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€7.77
Expected worth in 1 year
€7.49
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
€-0.28
Return On Investment
-2.3%

For what price can you sell your share?

Current Price per Share
€12.20
Expected price per share
€11.60 - €14.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of MYRIAD GENETICS (MYD.SG) (5 min.)




Live pricePrice per Share (EOD)
€12.20
Intrinsic Value Per Share
€9.83 - €12.50
Total Value Per Share
€17.60 - €20.27

2.2. Growth of MYRIAD GENETICS (MYD.SG) (5 min.)




Is MYRIAD GENETICS (MYD.SG) growing?

Current yearPrevious yearGrowGrow %
How rich?$731.7m$784.9m-$31m-4.1%

How much money is MYRIAD GENETICS (MYD.SG) making?

Current yearPrevious yearGrowGrow %
Making money-$29m-$68.6m$39.6m136.6%
Net Profit Margin-14.1%-37.3%--

How much money comes from the company's main activities?

2.3. Financial Health of MYRIAD GENETICS (MYD.SG) (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of MYRIAD GENETICS (MYD.SG)?

Welcome investor! MYRIAD GENETICS (MYD.SG)'s management wants to use your money to grow the business. In return you get a share of MYRIAD GENETICS (MYD.SG).

First you should know what it really means to hold a share of MYRIAD GENETICS (MYD.SG). And how you can make/lose money.

Speculation

The Price per Share of MYRIAD GENETICS (MYD.SG) is €12.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of MYRIAD GENETICS (MYD.SG).
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in MYRIAD GENETICS (MYD.SG), you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €7.77. Based on the TTM, the Book Value Change Per Share is €-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of MYRIAD GENETICS (MYD.SG).

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.24-2.0%-0.32-2.6%-0.84-6.9%-0.45-3.7%-0.39-3.2%
Usd Book Value Change Per Share-0.11-0.9%-0.07-0.6%-0.75-6.2%0.403.3%0.403.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-0.9%-0.07-0.6%-0.75-6.2%0.403.3%0.403.3%
Usd Price Per Share24.84-21.73-18.76-20.34-17.69-
Price to Earnings Ratio-25.56--17.76--6.10--20.10--17.48-
Price-to-Total Gains Ratio-235.05--86.28--27.41--62.63--62.63-
Price to Book Ratio3.09-2.62-1.98-1.93-1.68-
Price-to-Total Gains Ratio-235.05--86.28--27.41--62.63--62.63-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.62456
Number of shares79
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.40
Usd Total Gains Per Share-0.070.40
Gains per Quarter (79 shares)-5.6731.76
Gains per Year (79 shares)-22.67127.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-23-330127117
20-45-560254244
30-68-790381371
40-91-1020508498
50-113-1250635625
60-136-1480762752
70-159-1710889879
80-181-194010161006
90-204-217011431133
100-227-240012701260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.019.00.05.0%1.019.00.05.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%4.016.00.020.0%4.016.00.020.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%4.016.00.020.0%4.016.00.020.0%4.016.00.020.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of MYRIAD GENETICS (MYD.SG) compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.102-0.069-32%-0.725+610%0.389-126%0.389-126%
Book Value Per Share--7.7708.044-3%9.292-16%10.509-26%9.138-15%
Current Ratio--1.9001.964-3%1.607+18%2.297-17%2.387-20%
Debt To Asset Ratio--0.3230.318+2%0.333-3%0.314+3%0.314+3%
Debt To Equity Ratio--0.4780.467+2%0.512-7%0.465+3%0.464+3%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--1846146560.0001562912200.000+18%1102753661.350+67%1210652839.270+52%1210652839.270+52%
Eps---0.235-0.309+32%-0.811+246%-0.437+86%-0.380+62%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--2.2391.956+14%1.557+44%1.750+28%1.750+28%
Free Cash Flow Per Share---0.059-0.288+383%-0.409+588%-0.254+326%-0.254+326%
Free Cash Flow To Equity Per Share---0.0920.015-727%-0.324+251%-0.274+197%-0.274+197%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--12.502--------
Intrinsic Value_10Y_min--9.828--------
Intrinsic Value_1Y_max---1.103--------
Intrinsic Value_1Y_min---1.085--------
Intrinsic Value_3Y_max---1.520--------
Intrinsic Value_3Y_min---1.487--------
Intrinsic Value_5Y_max--0.229--------
Intrinsic Value_5Y_min--0.058--------
Market Cap--2184000000.0001903085000.000+15%1480785181.350+47%1598039111.270+37%1389599227.191+57%
Net Profit Margin---0.104-0.141+36%-0.373+260%-0.218+111%-0.194+87%
Operating Margin----0%-0%-0.0770%-0.0590%
Operating Ratio--1.3811.290+7%1.531-10%1.503-8%1.473-6%
Pb Ratio1.570-97%3.0892.622+18%1.980+56%1.933+60%1.681+84%
Pe Ratio-12.995+49%-25.565-17.757-31%-6.103-76%-20.097-21%-17.476-32%
Price Per Share12.200-97%24.00021.000+14%18.128+32%19.655+22%17.091+40%
Price To Free Cash Flow Ratio-51.286+49%-100.890-51.916-49%-13.154-87%-19.496-81%-16.953-83%
Price To Total Gains Ratio-119.485+49%-235.052-86.280-63%-27.413-88%-62.631-73%-62.631-73%
Quick Ratio--0.8150.822-1%0.840-3%0.985-17%1.069-24%
Return On Assets---0.020-0.026+28%-0.058+185%-0.029+42%-0.026+26%
Return On Equity---0.030-0.038+27%-0.090+199%-0.044+45%-0.039+29%
Total Gains Per Share---0.102-0.069-32%-0.725+610%0.389-126%0.389-126%
Usd Book Value--731722477.824753873158.272-3%784924112.128-7%871771780.006-16%899158056.070-19%
Usd Book Value Change Per Share---0.106-0.072-32%-0.751+610%0.402-126%0.402-126%
Usd Book Value Per Share--8.0418.324-3%9.616-16%10.875-26%9.456-15%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--1910392460.2881617301544.560+18%1141129488.765+67%1252783558.077+52%1252783558.077+52%
Usd Eps---0.243-0.320+32%-0.839+246%-0.453+86%-0.394+62%
Usd Free Cash Flow---5600172.032-26825824.064+379%-34576062.144+517%-20725636.672+270%-18022292.758+222%
Usd Free Cash Flow Per Share---0.062-0.298+383%-0.423+588%-0.262+326%-0.262+326%
Usd Free Cash Flow To Equity Per Share---0.0960.015-727%-0.335+251%-0.284+197%-0.284+197%
Usd Market Cap--2260003200.0001969312358.000+15%1532316505.661+47%1653650872.342+37%1437957280.298+57%
Usd Price Per Share12.625-97%24.83521.731+14%18.758+32%20.339+22%17.686+40%
Usd Profit---22100678.912-29000890.880+31%-68602107.392+210%-36281114.522+64%-32327080.014+46%
Usd Revenue--213306552.576205906325.248+4%183605640.192+16%175070377.997+22%179118545.831+19%
Usd Total Gains Per Share---0.106-0.072-32%-0.751+610%0.402-126%0.402-126%
 EOD+3 -3MRQTTM+18 -17YOY+28 -75Y+21 -1410Y+21 -14

3.3 Fundamental Score

Let's check the fundamental score of MYRIAD GENETICS (MYD.SG) based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.995
Price to Book Ratio (EOD)Between0-11.570
Net Profit Margin (MRQ)Greater than0-0.104
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.815
Current Ratio (MRQ)Greater than11.900
Debt to Asset Ratio (MRQ)Less than10.323
Debt to Equity Ratio (MRQ)Less than10.478
Return on Equity (MRQ)Greater than0.15-0.030
Return on Assets (MRQ)Greater than0.05-0.020
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of MYRIAD GENETICS (MYD.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.488
Ma 20Greater thanMa 5012.615
Ma 50Greater thanMa 10013.544
Ma 100Greater thanMa 20017.427
OpenGreater thanClose12.300
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About MYRIAD GENETICS (MYD.SG)

  • Other
  • 0

There is no Profile data available for MYD.SG.

Fundamental data was last updated by Penke on 2025-01-29 03:25:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit MYRIAD GENETICS (MYD.SG) earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • A Net Profit Margin of -10.4% means that €-0.10 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is -10.4%. The company is making a huge loss. -2
  • The TTM is -14.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10.4%TTM-14.1%+3.7%
TTM-14.1%YOY-37.3%+23.2%
TTM-14.1%5Y-21.8%+7.7%
5Y-21.8%10Y-19.4%-2.4%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.4%5.6%-16.0%
TTM-14.1%6.1%-20.2%
YOY-37.3%6.9%-44.2%
5Y-21.8%6.4%-28.2%
10Y-19.4%6.5%-25.9%
4.3.1.2. Return on Assets

Shows how efficient MYRIAD GENETICS (MYD.SG) is using its assets to generate profit.

  • Above 5% is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • -2.0% Return on Assets means that MYRIAD GENETICS (MYD.SG) generated €-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-2.6%+0.6%
TTM-2.6%YOY-5.8%+3.2%
TTM-2.6%5Y-2.9%+0.3%
5Y-2.9%10Y-2.6%-0.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%1.9%-3.9%
TTM-2.6%1.7%-4.3%
YOY-5.8%2.0%-7.8%
5Y-2.9%2.0%-4.9%
10Y-2.6%2.0%-4.6%
4.3.1.3. Return on Equity

Shows how efficient MYRIAD GENETICS (MYD.SG) is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • -3.0% Return on Equity means MYRIAD GENETICS (MYD.SG) generated €-0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is -3.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-3.8%+0.8%
TTM-3.8%YOY-9.0%+5.2%
TTM-3.8%5Y-4.4%+0.5%
5Y-4.4%10Y-3.9%-0.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%4.7%-7.7%
TTM-3.8%4.2%-8.0%
YOY-9.0%6.3%-15.3%
5Y-4.4%5.6%-10.0%
10Y-3.9%5.4%-9.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of MYRIAD GENETICS (MYD.SG).

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient MYRIAD GENETICS (MYD.SG) is operating .

  • Measures how much profit MYRIAD GENETICS (MYD.SG) makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-7.7%+7.7%
5Y-7.7%10Y-5.9%-1.8%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-14.1%
TTM-8.2%-8.2%
YOY-7.6%-7.6%
5Y-7.7%5.4%-13.1%
10Y-5.9%8.3%-14.2%
4.3.2.2. Operating Ratio

Measures how efficient MYRIAD GENETICS (MYD.SG) is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are €1.38 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 1.381. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.290. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.381TTM1.290+0.091
TTM1.290YOY1.531-0.241
TTM1.2905Y1.503-0.213
5Y1.50310Y1.473+0.029
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3811.310+0.071
TTM1.2901.379-0.089
YOY1.5311.335+0.196
5Y1.5031.302+0.201
10Y1.4731.388+0.085
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of MYRIAD GENETICS (MYD.SG).

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if MYRIAD GENETICS (MYD.SG) is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 1.90 means the company has €1.90 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 1.900. The company is able to pay all its short-term debts. +1
  • The TTM is 1.964. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.900TTM1.964-0.064
TTM1.964YOY1.607+0.358
TTM1.9645Y2.297-0.333
5Y2.29710Y2.387-0.090
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9001.458+0.442
TTM1.9641.449+0.515
YOY1.6071.555+0.052
5Y2.2971.537+0.760
10Y2.3871.487+0.900
4.4.3.2. Quick Ratio

Measures if MYRIAD GENETICS (MYD.SG) is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • A Quick Ratio of 0.81 means the company can pay off €0.81 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 0.815. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.822. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.815TTM0.822-0.007
TTM0.822YOY0.840-0.018
TTM0.8225Y0.985-0.164
5Y0.98510Y1.069-0.084
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8150.556+0.259
TTM0.8220.563+0.259
YOY0.8400.585+0.255
5Y0.9850.586+0.399
10Y1.0690.610+0.459
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of MYRIAD GENETICS (MYD.SG).

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of MYRIAD GENETICS (MYD.SG) assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to Other industry mean.
  • A Debt to Asset Ratio of 0.32 means that MYRIAD GENETICS (MYD.SG) assets are financed with 32.3% credit (debt) and the remaining percentage (100% - 32.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 0.323. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.318. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.323TTM0.318+0.005
TTM0.318YOY0.333-0.015
TTM0.3185Y0.314+0.004
5Y0.31410Y0.314+0.000
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3230.522-0.199
TTM0.3180.527-0.209
YOY0.3330.532-0.199
5Y0.3140.559-0.245
10Y0.3140.564-0.250
4.5.4.2. Debt to Equity Ratio

Measures if MYRIAD GENETICS (MYD.SG) is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • A Debt to Equity ratio of 47.8% means that company has €0.48 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The MRQ is 0.478. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.467. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.478TTM0.467+0.011
TTM0.467YOY0.512-0.045
TTM0.4675Y0.465+0.002
5Y0.46510Y0.464+0.002
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4781.095-0.617
TTM0.4671.105-0.638
YOY0.5121.168-0.656
5Y0.4651.338-0.873
10Y0.4641.434-0.970
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings MYRIAD GENETICS (MYD.SG) generates.

  • Above 15 is considered overpriced but always compare MYRIAD GENETICS (MYD.SG) to the Other industry mean.
  • A PE ratio of -25.56 means the investor is paying €-25.56 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The EOD is -12.995. Based on the earnings, the company is expensive. -2
  • The MRQ is -25.565. Based on the earnings, the company is expensive. -2
  • The TTM is -17.757. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.995MRQ-25.565+12.569
MRQ-25.565TTM-17.757-7.807
TTM-17.757YOY-6.103-11.655
TTM-17.7575Y-20.097+2.340
5Y-20.09710Y-17.476-2.621
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-12.99514.831-27.826
MRQ-25.56513.725-39.290
TTM-17.75712.895-30.652
YOY-6.10311.417-17.520
5Y-20.09713.364-33.461
10Y-17.47613.855-31.331
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The EOD is -51.286. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -100.890. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -51.916. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-51.286MRQ-100.890+49.604
MRQ-100.890TTM-51.916-48.974
TTM-51.916YOY-13.154-38.762
TTM-51.9165Y-19.496-32.420
5Y-19.49610Y-16.953-2.543
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-51.2867.638-58.924
MRQ-100.8907.713-108.603
TTM-51.9167.631-59.547
YOY-13.1546.435-19.589
5Y-19.4965.353-24.849
10Y-16.9534.892-21.845
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of MYRIAD GENETICS (MYD.SG) is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 3.09 means the investor is paying €3.09 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of MYRIAD GENETICS (MYD.SG):

  • The EOD is 1.570. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.089. Based on the equity, the company is fair priced.
  • The TTM is 2.622. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.570MRQ3.089-1.519
MRQ3.089TTM2.622+0.467
TTM2.622YOY1.980+0.642
TTM2.6225Y1.933+0.689
5Y1.93310Y1.681+0.252
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD1.5701.624-0.054
MRQ3.0891.445+1.644
TTM2.6221.365+1.257
YOY1.9801.323+0.657
5Y1.9331.794+0.139
10Y1.6811.701-0.020
4.6.2. Total Gains per Share

2.4. Latest News of MYRIAD GENETICS (MYD.SG)

Does MYRIAD GENETICS (MYD.SG) still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from MYRIAD GENETICS (MYD.SG) to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-01-25
02:08
Why Is Larry Robbins Bullish on Myriad Genetics, Inc. (MYGN) Now?Read
2025-01-21
14:30
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & GynecologyRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,081,300
Total Liabilities349,600
Total Stockholder Equity731,700
 As reported
Total Liabilities 349,600
Total Stockholder Equity+ 731,700
Total Assets = 1,081,300

Assets

Total Assets1,081,300
Total Current Assets293,200
Long-term Assets788,100
Total Current Assets
Cash And Cash Equivalents 99,900
Net Receivables 125,700
Inventory 26,200
Other Current Assets 24,400
Total Current Assets  (as reported)293,200
Total Current Assets  (calculated)276,200
+/- 17,000
Long-term Assets
Property Plant Equipment 172,800
Goodwill 286,300
Intangible Assets 312,500
Long-term Assets Other 16,500
Long-term Assets  (as reported)788,100
Long-term Assets  (calculated)788,100
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities154,300
Long-term Liabilities195,300
Total Stockholder Equity731,700
Total Current Liabilities
Accounts payable 29,600
Total Current Liabilities  (as reported)154,300
Total Current Liabilities  (calculated)29,600
+/- 124,700
Long-term Liabilities
Long term Debt 39,000
Capital Lease Obligations Min Short Term Debt104,100
Long-term Liabilities Other 34,300
Long-term Liabilities  (as reported)195,300
Long-term Liabilities  (calculated)177,400
+/- 17,900
Total Stockholder Equity
Total Stockholder Equity (as reported)731,700
Total Stockholder Equity (calculated)0
+/- 731,700
Other
Capital Stock900
Common Stock Shares Outstanding 91,000
Net Invested Capital 770,700
Net Working Capital 138,900
Property Plant and Equipment Gross 290,100



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
1,557,300
1,562,700
1,591,200
1,578,300
1,446,700
1,404,600
1,444,500
1,418,800
1,336,900
1,360,300
1,335,900
1,320,700
1,255,400
1,210,200
1,212,000
1,198,700
1,169,300
1,187,200
1,149,100
1,146,500
1,110,500
1,085,100
1,081,300
1,081,3001,085,1001,110,5001,146,5001,149,1001,187,2001,169,3001,198,7001,212,0001,210,2001,255,4001,320,7001,335,9001,360,3001,336,9001,418,8001,444,5001,404,6001,446,7001,578,3001,591,2001,562,7001,557,300
   > Total Current Assets 
342,900
348,600
329,500
365,300
355,200
331,700
394,500
389,400
329,200
538,900
498,900
484,800
427,400
367,100
352,300
274,600
261,600
294,300
265,400
313,600
290,300
291,600
293,200
293,200291,600290,300313,600265,400294,300261,600274,600352,300367,100427,400484,800498,900538,900329,200389,400394,500331,700355,200365,300329,500348,600342,900
       Cash And Cash Equivalents 
84,900
93,200
89,900
81,200
121,000
163,700
118,300
117,000
148,900
118,400
295,200
258,400
165,200
105,200
110,700
56,900
53,600
102,800
76,000
132,100
96,900
92,400
99,900
99,90092,40096,900132,10076,000102,80053,60056,900110,700105,200165,200258,400295,200118,400148,900117,000118,300163,700121,00081,20089,90093,20084,900
       Short-term Investments 
64,800
43,700
52,700
60,400
60,500
54,100
42,100
33,700
27,200
46,000
70,900
81,400
103,200
99,900
82,500
58,000
25,100
18,800
10,300
8,800
7,400
4,900
0
04,9007,4008,80010,30018,80025,10058,00082,50099,900103,20081,40070,90046,00027,20033,70042,10054,10060,50060,40052,70043,70064,800
       Net Receivables 
142,600
133,900
117,000
118,300
102,500
68,100
85,100
89,500
94,100
94,800
93,600
91,300
101,700
109,800
102,200
101,600
119,100
111,700
115,200
114,300
118,100
117,800
125,700
125,700117,800118,100114,300115,200111,700119,100101,600102,200109,800101,70091,30093,60094,80094,10089,50085,10068,100102,500118,300117,000133,900142,600
       Inventory 
31,900
31,400
28,100
28,100
30,800
29,100
26,600
27,100
24,600
17,700
18,600
15,300
15,600
15,400
19,600
20,100
21,800
22,500
25,100
22,000
24,600
26,100
26,200
26,20026,10024,60022,00025,10022,50021,80020,10019,60015,40015,60015,30018,60017,70024,60027,10026,60029,10030,80028,10028,10031,40031,900
   > Long-term Assets 
1,214,400
1,214,100
1,261,700
1,213,000
1,091,600
1,072,900
1,050,000
1,029,400
1,007,700
821,400
837,000
835,900
828,000
843,100
859,700
924,100
907,700
892,900
883,700
832,900
820,200
793,500
788,100
788,100793,500820,200832,900883,700892,900907,700924,100859,700843,100828,000835,900837,000821,4001,007,7001,029,4001,050,0001,072,9001,091,6001,213,0001,261,7001,214,1001,214,400
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
178,100
187,300
203,300
218,600
224,700
180,600
177,400
172,800
172,800
172,800172,800177,400180,600224,700218,600203,300187,300178,10000000000000000
       Goodwill 
415,900
417,200
416,100
408,100
327,100
327,600
328,300
329,200
328,300
240,100
239,700
239,200
238,800
237,800
236,500
286,800
287,100
287,200
286,600
287,400
287,000
286,300
286,300
286,300286,300287,000287,400286,600287,200287,100286,800236,500237,800238,800239,200239,700240,100328,300329,200328,300327,600327,100408,100416,100417,200415,900
       Long Term Investments 
40,300
54,900
51,500
47,600
42,800
37,000
30,200
21,000
11,900
19,900
47,500
59,000
70,800
78,500
66,000
54,800
30,400
6,200
0
0
0
0
0
000006,20030,40054,80066,00078,50070,80059,00047,50019,90011,90021,00030,20037,00042,80047,60051,50054,90040,300
       Intangible Assets 
699,500
684,700
667,800
653,500
620,100
605,300
590,900
576,500
559,900
426,800
414,800
404,100
393,600
382,300
370,800
379,700
369,400
358,800
356,600
349,500
340,900
319,500
312,500
312,500319,500340,900349,500356,600358,800369,400379,700370,800382,300393,600404,100414,800426,800559,900576,500590,900605,300620,100653,500667,800684,700699,500
> Total Liabilities 
475,600
473,800
516,700
501,000
479,500
486,400
535,200
538,900
461,700
457,900
367,400
352,900
305,300
262,800
295,400
312,900
334,100
452,000
465,700
363,300
350,500
344,600
349,600
349,600344,600350,500363,300465,700452,000334,100312,900295,400262,800305,300352,900367,400457,900461,700538,900535,200486,400479,500501,000516,700473,800475,600
   > Total Current Liabilities 
108,900
117,800
115,400
112,400
113,200
147,000
133,700
145,900
149,000
271,000
203,200
204,300
166,000
119,700
129,100
137,200
143,300
221,100
209,300
155,900
146,100
148,900
154,300
154,300148,900146,100155,900209,300221,100143,300137,200129,100119,700166,000204,300203,200271,000149,000145,900133,700147,000113,200112,400115,400117,800108,900
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
104,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000104,100000000000
       Accounts payable 
24,100
33,300
24,000
21,000
30,300
21,700
19,100
20,500
20,800
28,500
15,700
29,600
27,100
21,700
29,600
28,800
36,500
39,800
33,900
25,800
33,100
33,300
29,600
29,60033,30033,10025,80033,90039,80036,50028,80029,60021,70027,10029,60015,70028,50020,80020,50019,10021,70030,30021,00024,00033,30024,100
       Other Current Liabilities 
3,700
3,400
3,300
13,900
3,100
3,100
3,300
0
0
12,200
0
0
0
0
0
0
0
0
0
10,400
0
4,000
0
04,000010,40000000000012,200003,3003,1003,10013,9003,3003,4003,700
   > Long-term Liabilities 
366,700
356,000
401,300
388,600
366,300
339,400
401,500
393,000
312,700
186,900
164,200
148,600
139,300
143,100
166,300
175,700
190,800
230,900
256,400
207,400
204,400
195,700
195,300
195,300195,700204,400207,400256,400230,900190,800175,700166,300143,100139,300148,600164,200186,900312,700393,000401,500339,400366,300388,600401,300356,000366,700
       Long term Debt 
263,400
233,500
225,000
225,100
225,200
224,400
224,600
224,800
154,000
0
0
0
0
0
0
0
0
38,400
38,500
38,500
38,700
38,800
39,000
39,00038,80038,70038,50038,50038,40000000000154,000224,800224,600224,400225,200225,100225,000233,500263,400
       Capital Lease Obligations Min Short Term Debt
0
0
75,600
71,500
68,800
70,400
67,100
64,200
63,400
96,600
93,500
92,300
89,900
100,700
137,300
145,000
161,600
165,400
162,900
113,600
108,100
104,500
104,100
104,100104,500108,100113,600162,900165,400161,600145,000137,300100,70089,90092,30093,50096,60063,40064,20067,10070,40068,80071,50075,60000
       Long-term Liabilities Other 
11,500
11,400
7,900
6,900
3,600
8,000
10,700
45,100
50,100
44,800
42,800
33,500
32,900
32,400
32,500
18,000
11,500
11,400
40,500
41,300
40,600
34,600
34,300
34,30034,60040,60041,30040,50011,40011,50018,00032,50032,40032,90033,50042,80044,80050,10045,10010,7008,0003,6006,9007,90011,40011,500
> Total Stockholder Equity
1,081,800
1,088,900
1,074,500
1,077,200
967,200
918,200
909,300
879,900
875,200
902,500
968,600
967,800
950,100
947,400
916,600
885,800
835,200
735,200
683,400
783,200
760,000
740,500
731,700
731,700740,500760,000783,200683,400735,200835,200885,800916,600947,400950,100967,800968,600902,500875,200879,900909,300918,200967,2001,077,2001,074,5001,088,9001,081,800
   Common Stock00000000000000000000000
   Retained Earnings 
29,800
25,600
5,000
-3,300
-118,500
-173,900
-189,100
-233,300
-266,500
-271,200
-246,600
-254,200
-274,700
-288,800
-323,900
-366,200
-420,900
-537,000
-598,300
-629,500
-655,500
-692,200
-714,300
-714,300-692,200-655,500-629,500-598,300-537,000-420,900-366,200-323,900-288,800-274,700-254,200-246,600-271,200-266,500-233,300-189,100-173,900-118,500-3,3005,00025,60029,800
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 00000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue753,200
Cost of Revenue-236,200
Gross Profit517,000517,000
 
Operating Income (+$)
Gross Profit517,000
Operating Expense-897,800
Operating Income-144,600-380,800
 
Operating Expense (+$)
Research Development88,700
Selling General Administrative572,900
Selling And Marketing Expenses-
Operating Expense897,800661,600
 
Net Interest Income (+$)
Interest Income2,500
Interest Expense-2,900
Other Finance Cost-0
Net Interest Income-400
 
Pretax Income (+$)
Operating Income-144,600
Net Interest Income-400
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-262,200-27,400
EBIT - interestExpense = -2,900
-263,300
-260,400
Interest Expense2,900
Earnings Before Interest and Taxes (EBIT)--259,300
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-262,200
Tax Provision-1,100
Net Income From Continuing Ops-263,300-263,300
Net Income-263,300
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-117,200400
 

Technical Analysis of MYRIAD GENETICS (MYD.SG)
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of MYRIAD GENETICS (MYD.SG). The general trend of MYRIAD GENETICS (MYD.SG) is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine MYRIAD GENETICS (MYD.SG)'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MYRIAD GENETICS (MYD.SG).

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.50 < 14.00 < 14.50.

The bearish price targets are: 11.60.

Tweet this
MYRIAD GENETICS (MYD.SG) Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MYRIAD GENETICS (MYD.SG). The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MYRIAD GENETICS (MYD.SG) Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MYRIAD GENETICS (MYD.SG). The current macd is -0.5183531.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MYRIAD GENETICS (MYD.SG) price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for MYRIAD GENETICS (MYD.SG). This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the MYRIAD GENETICS (MYD.SG) price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MYRIAD GENETICS (MYD.SG) Daily Moving Average Convergence/Divergence (MACD) ChartMYRIAD GENETICS (MYD.SG) Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MYRIAD GENETICS (MYD.SG). The current adx is 24.84.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell MYRIAD GENETICS (MYD.SG) shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
MYRIAD GENETICS (MYD.SG) Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MYRIAD GENETICS (MYD.SG). The current sar is 12.58.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
MYRIAD GENETICS (MYD.SG) Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MYRIAD GENETICS (MYD.SG). The current rsi is 41.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
MYRIAD GENETICS (MYD.SG) Daily Relative Strength Index (RSI) ChartMYRIAD GENETICS (MYD.SG) Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MYRIAD GENETICS (MYD.SG). The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the MYRIAD GENETICS (MYD.SG) price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
MYRIAD GENETICS (MYD.SG) Daily Stochastic Oscillator ChartMYRIAD GENETICS (MYD.SG) Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MYRIAD GENETICS (MYD.SG). The current cci is -37.33208372.

MYRIAD GENETICS (MYD.SG) Daily Commodity Channel Index (CCI) ChartMYRIAD GENETICS (MYD.SG) Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MYRIAD GENETICS (MYD.SG). The current cmo is -9.84580822.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MYRIAD GENETICS (MYD.SG) Daily Chande Momentum Oscillator (CMO) ChartMYRIAD GENETICS (MYD.SG) Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MYRIAD GENETICS (MYD.SG). The current willr is -72.72727273.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that MYRIAD GENETICS (MYD.SG) is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MYRIAD GENETICS (MYD.SG) Daily Williams %R ChartMYRIAD GENETICS (MYD.SG) Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MYRIAD GENETICS (MYD.SG).

MYRIAD GENETICS (MYD.SG) Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MYRIAD GENETICS (MYD.SG). The current atr is 0.33169594.

MYRIAD GENETICS (MYD.SG) Daily Average True Range (ATR) ChartMYRIAD GENETICS (MYD.SG) Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MYRIAD GENETICS (MYD.SG). The current obv is -350.

MYRIAD GENETICS (MYD.SG) Daily On-Balance Volume (OBV) ChartMYRIAD GENETICS (MYD.SG) Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MYRIAD GENETICS (MYD.SG). The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
MYRIAD GENETICS (MYD.SG) Daily Money Flow Index (MFI) ChartMYRIAD GENETICS (MYD.SG) Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MYRIAD GENETICS (MYD.SG).

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-31STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

MYRIAD GENETICS (MYD.SG) Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MYRIAD GENETICS (MYD.SG) based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.488
Ma 20Greater thanMa 5012.615
Ma 50Greater thanMa 10013.544
Ma 100Greater thanMa 20017.427
OpenGreater thanClose12.300
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of MYRIAD GENETICS (MYD.SG) with someone you think should read this too:
  • Are you bullish or bearish on MYRIAD GENETICS (MYD.SG)? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about MYRIAD GENETICS (MYD.SG)? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MYRIAD GENETICS (MYD.SG)

I send you an email if I find something interesting about MYRIAD GENETICS (MYD.SG).


Comments

How you think about this?

Leave a comment

Stay informed about MYRIAD GENETICS (MYD.SG).

Receive notifications about MYRIAD GENETICS (MYD.SG) in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.